NCT02895100Phase 2Terminated

Safety and Efficacy Study of PTG-100 in the Treatment of Moderate to Severe Ulcerative Colitis

Study sponsor: Protagonist Therapeutics, Inc. · PTGX

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2018-03-26Actual
Enrollment · participants98Actual
Source updated2025-08-21Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.